Enobosarm
PLATEAU
Veru Inc · Phase 2 · Active, not recruiting · Enrollment 239
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Subcutaneous injectable semaglutide and oral enobosarm 3mg | Obesity or overweight | 3mg | n/r | n/r | n/r |
| Subcutaneous injectable semaglutide and oral Placebo | Obesity or overweight | n/r | n/r | n/r | n/r |